Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Travel Vaccines Market Size, Value And Growth Trajectory Through 2030
The travel vaccines market size has experienced significant growth in recent years. This market is anticipated to expand from $5.09 billion in 2025 to $5.56 billion in 2026, registering a compound annual growth rate (CAGR) of 9.2%. Historically, the expansion can be attributed to several factors including limited vaccine access in emerging markets, low public awareness of travel-related diseases, reliance on traditional vaccination centers, regulatory approvals for mono vaccines, and the slow adoption of online booking platforms.
The travel vaccines market is projected to experience substantial expansion in the coming years. By 2030, its value is expected to reach $8.16 billion, achieving a compound annual growth rate (CAGR) of 10.0%. This expansion throughout the forecast period stems from factors such as heightened global travel and mobility, progress in biotechnology leading to combination vaccines, the proliferation of digital health and telemedicine services, greater understanding of preventive healthcare, and the broadening of international travel immunization initiatives. Key developments anticipated during this timeframe involve a surge in global tourism and business trips, a heightened focus on preventive health for travelers, the expansion of online platforms for travel health services and bookings, the creation of combined and multivalent travel vaccines, and an increase in collaborative public-private efforts for worldwide immunization schemes.
Get A Free Sample Report With In-Depth Market Insights:
Travel Vaccines Market Growth Drivers: What’s Behind The Acceleration?
The escalating trend in travel and tourism is anticipated to propel the expansion of the travel vaccine market going forward. Travel and tourism encompass the movement of people or items, including vehicles such as trains, boats, and airplanes, between diverse remote geographic locations. Travel vaccines prove beneficial for tourists and travelers by keeping them safe and healthy during their international journeys. For instance, in May 2025, according to UN Tourism, a Spain-based specialized agency responsible for promoting responsible, sustainable, and universally accessible tourism, the first three months of 2025 saw over 300 million tourists traveling internationally. This figure was approximately 14 million more than during the same period in 2024, marking a 5% year-on-year increase. Therefore, the surge in travel and tourism is driving the growth of the travel vaccine market.
Travel Vaccines Market Segment Landscape And Growth Outlook
The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel
Travel Vaccines Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies operating in the travel vaccine market are engaged in creating innovative vaccines to offer active immunization, thereby preventing Hepatitis A, a common concern for travelers. A travel vaccine is specifically formulated to shield individuals from infectious diseases prevalent in particular regions or countries, often recommended for those visiting such areas. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology firm, introduced Havisure, which stands as India’s first indigenously developed Hepatitis A vaccine. Havisure is projected to be crucial in delivering protection against the Hepatitis A virus, which predominantly affects the liver. This vaccine proves effective in averting the illness and is recommended for children as part of their routine immunization. Moreover, it is advised for individuals susceptible to exposure or those traveling to locations with elevated rates of hepatitis A.
Travel Vaccines Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd
View The Full Travel Vaccines Market Report:
Travel Vaccines Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the travel vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
